Study protocol

Design of a prospective clinical study on the agreement between the Continuous GlucoseMonitor, a novel device for CONTinuous ASSessment of blood GLUcose levels, and the RAPIDLab® 1265 blood gas analyser: The CONTASSGLU study

Johannes B Zimmermann^*, Monika Lehmann, Stefan Hofer, Johannes Hüsing, Catharina Alles, Jens Werner, Jürgen Stiller, Wolfgang Künnecke, Steffen Luntz, Johann Motsch^† and Markus A Weigand^†

* Corresponding author: Johannes B Zimmermann j.zimmermann@med.uni-heidelberg.de
† Equal contributors

BMC Anesthesiology 2012, 12:24 doi:10.1186/1471-2253-12-24

Accesses

Last 30 days: 202 accesses
Last 365 days: 1216 accesses
All time: 1216 accesses

BMC Anesthesiology

Viewing options

Associated material

Tools

Share this article

Design of a prospective clinical study on the agreement between the Continuous GlucoseMonitor, a novel device for CONTinuous ASSessment of blood GLUcose levels, and the RAPIDLab® 1265 blood gas analyser: The CONTASSGLU study

Accesses

Cited by

BioMed Central: 1 citation

Google Scholar: View citations

PubMed Central: View citations

BMC Anesthesiology

Viewing options

Associated material

Related literature

Cited by

Other articles by authors

Related articles/pages

Tools

Share this article

Design of a prospective clinical study on the agreement between the Continuous GlucoseMonitor, a novel device for CONTinuous ASSessment of blood GLUcose levels, and the RAPIDLab® 1265 blood gas analyser: The CONTASSGLU study

Accesses

Cited by

BioMed Central: 1 citation

Google Scholar: View citations

PubMed Central: View citations